VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 52 filers reported holding VERRICA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,478 | -30.2% | 10,419 | +3.7% | 0.00% | – |
| Q2 2023 | $57,977 | +9.4% | 10,048 | +54.5% | 0.00% | – |
| Q1 2022 | $53,000 | -17.2% | 6,502 | -6.6% | 0.00% | – |
| Q4 2021 | $64,000 | -28.9% | 6,960 | -2.9% | 0.00% | – |
| Q3 2021 | $90,000 | +8.4% | 7,168 | -2.3% | 0.00% | – |
| Q2 2021 | $83,000 | -24.5% | 7,339 | +1.2% | 0.00% | – |
| Q1 2021 | $110,000 | +32.5% | 7,250 | +0.3% | 0.00% | – |
| Q4 2020 | $83,000 | +43.1% | 7,231 | -2.8% | 0.00% | – |
| Q3 2020 | $58,000 | -31.0% | 7,439 | -2.2% | 0.00% | – |
| Q2 2020 | $84,000 | +1.2% | 7,608 | -0.3% | 0.00% | – |
| Q1 2020 | $83,000 | -35.2% | 7,632 | -5.5% | 0.00% | – |
| Q4 2019 | $128,000 | +6.7% | 8,073 | -0.8% | 0.00% | – |
| Q3 2019 | $120,000 | +26.3% | 8,140 | -0.7% | 0.00% | – |
| Q2 2019 | $95,000 | +28.4% | 8,198 | +19.5% | 0.00% | – |
| Q1 2019 | $74,000 | +138.7% | 6,861 | +79.6% | 0.00% | – |
| Q4 2018 | $31,000 | -50.8% | 3,821 | -0.8% | 0.00% | – |
| Q3 2018 | $63,000 | – | 3,850 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 5,038,983 | $19,576,448 | 0.65% |
| BML Capital Management, LLC | 150,000 | $582,750 | 0.54% |
| Caligan Partners LP | 259,593 | $1,009,817 | 0.46% |
| Avoro Capital Advisors LLC | 2,954,064 | $11,476,539 | 0.18% |
| Boxer Capital, LLC | 166,955 | $648,620 | 0.04% |
| SteelPeak Wealth, LLC | 136,986 | $532,191 | 0.03% |
| Legacy Trust | 18,750 | $72,844 | 0.02% |
| Miracle Mile Advisors, LLC | 118,221 | $459,289 | 0.01% |
| SPC Financial, Inc. | 30,000 | $116,550 | 0.01% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 99,251 | $385,590 | 0.01% |